Warren Buffett’s Berkshire Hathaway scoops up more Sirius XM, boosting stake to 35%

Warren Buffett’s Berkshire Hathaway scoops up more Sirius XM, boosting stake to 35%


In this article

  • SIRI
  • BRK.A
Warren Buffett walks the floor and meets with Berkshire Hathaway shareholders ahead of their annual meeting in Omaha, Nebraska on May 3rd, 2024. 
David A. Grogan

Warren Buffett’s Berkshire Hathaway once again scooped up shares of Sirius XM, boosting its stake in the satellite radio company to over 35%.

The Omaha, Nebraska-based conglomerate purchased roughly 2.3 million shares for about $54 million in separate transactions Thursday through Monday, according to a filing with the Securities and Exchange Commission Monday evening. Berkshire now owns 35.4% of SiriusXM.

Berkshire first bought Liberty Media’s trackers in 2016 and started piling into SiriusXM’s tracking stocks in the beginning of 2024 in a likely merger arbitrage play. Billionaire John Malone’s Liberty Media completed its deal in early September to combine its tracking stocks with the rest of the radio company, as part of the reshuffling of his sprawling media empire. There was also a split-off of the Atlanta Braves baseball team into a separate, publicly traded company, which Berkshire also owns shares in.

Stock Chart IconStock chart icon

hide content
SiriusXM

Buffett has yet to mention the Siri bet publicly, and it’s not clear if the 94-year-old investor was behind it or if it’s the work of his investing lieutenants, either Ted Weschler or Todd Combs. Berkshire also purchased about 5 million shares in December.

SiriusXM had a rough 2024 with shares down a whopping 58% as the company grappled with subscriber losses and unfavorable demographic shifts. It’s not a favored stock on Wall Street. Out of the 16 analysts covering Siri, only three gave it a buy rating, according to FactSet.

The stock is up about 5% in the new year.



Source

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
Finance

Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy […]

Read More
Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’
Finance

Surging oil prices could wipe out benefits from Trump’s ‘big beautiful bill’

Key Points Raymond James estimates that what consumers pay in higher gas prices could total exactly what they’re set to gain with the tax changes under President Donald Trump’s “big beautiful bill.” The stimulus was expected to boost both the U.S. economy and markets in 2026.  While consumers may not get as much of a […]

Read More
Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves premarket: Kohl’s, Casey’s General Stores, Vertex Pharmaceuticals and more

Check out the companies making headlines before the bell: Kohl’s — Shares tumbled 9% after the retailer posted disappointing fourth-quarter revenue of $4.97 billion, below the LSEG consensus of $5.03 billion. On the other hand, fourth quarter earnings of $1.07 per share exceeded the expected 85 cents per share. Casey’s General Stores — The convenience […]

Read More